2 Nasdaq stocks bucking Monday's market drop

The Nasdaq Composite continued to lose ground, but these stocks held up.

| More on:
A nurse administers a vaccine into the arm of a woman wearing a mask.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Investors are getting hit on all sides by news that raises big concerns, and stocks haven't been able to inspire much confidence from traders on Wall Street.

The Nasdaq Composite (NASDAQINDEX: .IXIC) is now back to being down more than 20% from its highs, with a drop of more than 2% at 1.45pm ET that shows just how little conviction many investors have in high-growth stocks right now.

However, some stocks in the Nasdaq managed to hold up well even in Monday's decline. Moderna (NASDAQ: MRNA) was once again a beneficiary of troubling news on the health front, this time from China. Meanwhile, investors continued to look for safe havens, and that helped consumer products giant PepsiCo (NASDAQ: PEP) maintain a modest gain Monday afternoon.

China's COVID-19 cases boost vaccine stocks

Shares of Moderna were up more than 11% on Monday afternoon. The vaccine maker wasn't alone, with BioNTech (NASDAQ: BNTX) seeing gains of more than 12%.

The news that was behind the upward move for vaccine stocks came from China, where an outbreak of the Omicron variant of COVID-19 has prompted government officials to impose new lockdown measures and travel restrictions. More than 1,300 cases have appeared, with the majority coming from the northeastern province of Jilin. In addition, the city of Shenzhen has seen new cases, prompting a lockdown of the city. Even though the number of cases is relatively small, China has been adamant in following its zero-COVID policy.

Even more troubling is the fact that many of these cases involve a new subvariant of Omicron that shows signs of being more transmissible and more harmful for those who become infected. It's unknown how well Moderna and BioNTech's vaccines will protect against this "stealth Omicron" variant, but investors believe the companies can work to potentially refine their vaccines over time.

Meanwhile, Moderna announced a study with the goal of making a vaccine to protect people against HIV. Such a breakthrough would show that Moderna isn't a one-trick pony and prove once and for all the efficacy of its mRNA technology.

Pepsi is fizzing higher

Elsewhere, shares of PepsiCo were up a more modest 2%. The soft drink and snack foods manufacturer has traditionally had some defensive characteristics that make it an attractive investment for those seeking shelter from tough market environments.

PepsiCo has become a staple for millions of consumers around the world, and its brand name strength gives it a competitive advantage over many smaller companies in the food and beverage space. With many consumers devoted to its brands, PepsiCo is better able to pass on any cost increases in the ingredients that go into its products. That helps PepsiCo sustain its profit margin even when rival companies have to suffer declining earnings.

Dividend investors also appreciate PepsiCo. The stock yields 2.8% currently, and the company has an impressive streak of consistently boosting the amount of its quarterly dividend payments that dates back decades.

Perhaps best of all, PepsiCo hasn't been afraid to set trends rather than react to them. When consumers started demanding healthier options, PepsiCo was among the first major companies to respond aggressively by moving away from sugary soft drinks toward carbonated water and other now-popular beverage alternatives. Similar moves on the snack side of the business have built up even more loyalty for the company.

As inflation hits hard, PepsiCo is in a better position than most to avoid the brunt of higher prices. Stock investors appreciate that kind of protection now more than ever.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

A woman sits at her desk thinking. She is surrounded by projections of world maps on various screens with data appearing below them.
International Stock News

A clear case for international investing

US shares have outperformed Australian shares by a wide margin over the past 30 years.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
International Stock News

Prediction: Nvidia's recent unobtrusive maneuver could signal a big growth move ahead.

Let's take a look.

Read more »

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
International Stock News

Prediction: This artificial intelligence (AI) stock could be the next Nvidia — and it's not what you think

Let's take a closer look at that name and see why it could turn out to be a solid addition…

Read more »

A woman in jeans and a casual jumper leans on her car and looks seriously at her mobile phone while her vehicle is charged at an electic vehicle recharging station.
International Stock News

Worried about Tesla's Robotaxi? These two words from Nvidia CEO Jensen Huang might change your mind.

Investors are on the edge of their seats as Tesla's robotaxi launch is reportedly around the corner.

Read more »

AI written in blue on a digital chip.
International Stock News

Warren Buffett has 23% of Berkshire Hathaway's portfolio invested in 2 AI stocks up 600% and 900% in the last decade

Here's what investors should know about these two stocks.

Read more »

Happy woman working on a laptop.
International Stock News

Want to invest in quantum computing? 3 stocks that are great buys right now.

They all give investors direct exposure to quantum computing, but aren't the all-or-nothing bets that some investors may regret going…

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

Billionaire Dan Loeb just sold Meta and Tesla stocks and piled into this hot AI stock up 1,500% over the past 5 years

Let's see what investors are thinking about these stocks today.

Read more »

A head shot of legendary investor Warren Buffett speaking into a microphone at an event.
International Stock News

Warren Buffett just spent $1.8 billion on 7 stocks. Here's the best of the bunch

Buffett's relatively small investments could be big opportunities for individual investors.

Read more »